Free Trial

Centene (CNC) Competitors

Centene logo
$65.11 +2.78 (+4.46%)
Closing price 06/8/2026 03:59 PM Eastern
Extended Trading
$64.06 -1.05 (-1.61%)
As of 06/8/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CNC vs. ELV, MOH, SEM, CI, and HUM

Should you buy Centene stock or one of its competitors? MarketBeat compares Centene with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Cigna Group (CI), and Humana (HUM). These companies are all part of the "medical" sector.

How does Centene compare to Elevance Health?

Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.

In the previous week, Elevance Health had 2 more articles in the media than Centene. MarketBeat recorded 16 mentions for Elevance Health and 14 mentions for Centene. Elevance Health's average media sentiment score of 1.20 beat Centene's score of 0.83 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
8 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Centene has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market. Comparatively, Elevance Health has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market.

Elevance Health has a net margin of 2.62% compared to Centene's net margin of -3.25%. Elevance Health's return on equity of 15.58% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene-3.25% 5.57% 1.54%
Elevance Health 2.62%15.58%5.57%

Centene presently has a consensus target price of $60.24, suggesting a potential downside of 7.49%. Elevance Health has a consensus target price of $416.11, suggesting a potential downside of 0.67%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts clearly believe Elevance Health is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
2 Sell rating(s)
9 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.37
Elevance Health
0 Sell rating(s)
9 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.61

93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.4% of Centene shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$194.78B0.17-$6.67B-$13.14N/A
Elevance Health$199.13B0.46$5.66B$23.5117.82

Summary

Elevance Health beats Centene on 13 of the 17 factors compared between the two stocks.

How does Centene compare to Molina Healthcare?

Centene (NYSE:CNC) and Molina Healthcare (NYSE:MOH) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.

Molina Healthcare has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$194.78B0.17-$6.67B-$13.14N/A
Molina Healthcare$45.43B0.23$472M$3.3858.68

In the previous week, Molina Healthcare had 4 more articles in the media than Centene. MarketBeat recorded 18 mentions for Molina Healthcare and 14 mentions for Centene. Molina Healthcare's average media sentiment score of 1.20 beat Centene's score of 0.83 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Molina Healthcare
12 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Molina Healthcare has a net margin of 0.42% compared to Centene's net margin of -3.25%. Molina Healthcare's return on equity of 8.76% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene-3.25% 5.57% 1.54%
Molina Healthcare 0.42%8.76%2.32%

Centene presently has a consensus price target of $60.24, suggesting a potential downside of 7.49%. Molina Healthcare has a consensus price target of $182.73, suggesting a potential downside of 7.87%. Given Centene's stronger consensus rating and higher probable upside, research analysts plainly believe Centene is more favorable than Molina Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
2 Sell rating(s)
9 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.37
Molina Healthcare
2 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.06

93.6% of Centene shares are held by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are held by institutional investors. 0.4% of Centene shares are held by insiders. Comparatively, 1.4% of Molina Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Centene has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market.

Summary

Molina Healthcare beats Centene on 11 of the 17 factors compared between the two stocks.

How does Centene compare to Select Medical?

Centene (NYSE:CNC) and Select Medical (NYSE:SEM) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

93.6% of Centene shares are held by institutional investors. Comparatively, 89.5% of Select Medical shares are held by institutional investors. 0.4% of Centene shares are held by insiders. Comparatively, 16.0% of Select Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Centene currently has a consensus target price of $60.24, suggesting a potential downside of 7.49%. Select Medical has a consensus target price of $15.50, suggesting a potential downside of 6.54%. Given Select Medical's higher possible upside, analysts clearly believe Select Medical is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
2 Sell rating(s)
9 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.37
Select Medical
0 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.14

Select Medical has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Select Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$194.78B0.17-$6.67B-$13.14N/A
Select Medical$5.52B0.37$146.22M$1.0615.65

In the previous week, Centene had 6 more articles in the media than Select Medical. MarketBeat recorded 14 mentions for Centene and 8 mentions for Select Medical. Centene's average media sentiment score of 0.83 beat Select Medical's score of 0.09 indicating that Centene is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Select Medical
0 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Select Medical has a net margin of 2.42% compared to Centene's net margin of -3.25%. Select Medical's return on equity of 6.62% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene-3.25% 5.57% 1.54%
Select Medical 2.42%6.62%2.30%

Centene has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market. Comparatively, Select Medical has a beta of 1.01, meaning that its stock price is 1% more volatile than the broader market.

Summary

Select Medical beats Centene on 9 of the 17 factors compared between the two stocks.

How does Centene compare to Cigna Group?

Cigna Group (NYSE:CI) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

87.0% of Cigna Group shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.6% of Cigna Group shares are held by insiders. Comparatively, 0.4% of Centene shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cigna Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cigna Group$274.90B0.28$5.96B$23.5912.28
Centene$194.78B0.17-$6.67B-$13.14N/A

In the previous week, Cigna Group had 16 more articles in the media than Centene. MarketBeat recorded 30 mentions for Cigna Group and 14 mentions for Centene. Cigna Group's average media sentiment score of 0.92 beat Centene's score of 0.83 indicating that Cigna Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cigna Group
19 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Centene
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cigna Group has a net margin of 2.26% compared to Centene's net margin of -3.25%. Cigna Group's return on equity of 19.75% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Cigna Group2.26% 19.75% 5.30%
Centene -3.25%5.57%1.54%

Cigna Group currently has a consensus target price of $338.80, suggesting a potential upside of 16.95%. Centene has a consensus target price of $60.24, suggesting a potential downside of 7.49%. Given Cigna Group's stronger consensus rating and higher possible upside, research analysts plainly believe Cigna Group is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cigna Group
0 Sell rating(s)
6 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.77
Centene
2 Sell rating(s)
9 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.37

Cigna Group has a beta of 0.28, suggesting that its stock price is 72% less volatile than the broader market. Comparatively, Centene has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market.

Summary

Cigna Group beats Centene on 14 of the 16 factors compared between the two stocks.

How does Centene compare to Humana?

Humana (NYSE:HUM) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

In the previous week, Centene had 1 more articles in the media than Humana. MarketBeat recorded 14 mentions for Centene and 13 mentions for Humana. Humana's average media sentiment score of 1.12 beat Centene's score of 0.83 indicating that Humana is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Humana
7 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Centene
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

92.4% of Humana shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.2% of Humana shares are held by company insiders. Comparatively, 0.4% of Centene shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Humana presently has a consensus price target of $286.13, suggesting a potential downside of 19.51%. Centene has a consensus price target of $60.24, suggesting a potential downside of 7.49%. Given Centene's stronger consensus rating and higher probable upside, analysts clearly believe Centene is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humana
4 Sell rating(s)
14 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.25
Centene
2 Sell rating(s)
9 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.37

Humana has a net margin of 0.82% compared to Centene's net margin of -3.25%. Humana's return on equity of 10.45% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Humana0.82% 10.45% 3.75%
Centene -3.25%5.57%1.54%

Humana has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Centene has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market.

Humana has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Humana$129.66B0.33$1.19B$9.3538.02
Centene$194.78B0.17-$6.67B-$13.14N/A

Summary

Humana beats Centene on 9 of the 16 factors compared between the two stocks.

Get Centene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNC vs. The Competition

MetricCenteneMED IndustryMedical SectorNYSE Exchange
Market Cap$30.78B$52.43B$6.49B$23.05B
Dividend YieldN/A1.73%2.67%4.10%
P/E Ratio-4.9623.8723.6830.30
Price / Sales0.170.62507.3322.46
Price / Cash13.3022.7626.9918.46
Price / Book1.602.6710.284.61
Net Income-$6.67B$1.46B$3.57B$1.07B
7 Day Performance8.69%3.42%0.28%-2.02%
1 Month Performance16.33%5.08%3.27%-1.20%
1 Year Performance16.88%-5.77%22.22%20.56%

Centene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNC
Centene
3.422 of 5 stars
$65.11
+4.5%
$60.24
-7.5%
+18.0%$30.78B$194.78BN/A61,100
ELV
Elevance Health
4.3165 of 5 stars
$402.69
+2.4%
$407.05
+1.1%
+6.4%$87.45B$199.13B17.1397,100
MOH
Molina Healthcare
2.8263 of 5 stars
$182.82
+5.3%
$178.53
-2.3%
-33.0%$9.52B$45.43B54.0919,000
SEM
Select Medical
3.2685 of 5 stars
$16.52
+0.1%
$15.50
-6.1%
+7.5%$2.05B$5.45B15.5845,300
CI
Cigna Group
4.8934 of 5 stars
$274.14
-1.2%
$339.50
+23.8%
-7.0%$72.52B$274.90B11.6267,700

Related Companies and Tools


This page (NYSE:CNC) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners